Email this article to a friend
Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment
Arthritis Research & Therapy 2008, 10:R125 doi:10.1186/ar2537
See related editorial by Maksymowych, http://arthritis-research.com/content/11/1/101
